253 related articles for article (PubMed ID: 34330766)
21. Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patients.
Fröhlich A; Niebel D; Fietz S; Egger E; Buchner A; Sirokay J; Landsberg J
Cancer Immunol Immunother; 2020 May; 69(5):759-769. PubMed ID: 32052079
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
Pisters PW; Pollock RE; Lewis VO; Yasko AW; Cormier JN; Respondek PM; Feig BW; Hunt KK; Lin PP; Zagars G; Wei C; Ballo MT
Ann Surg; 2007 Oct; 246(4):675-81; discussion 681-2. PubMed ID: 17893504
[TBL] [Abstract][Full Text] [Related]
23. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study.
Gimeno M; San Julián M; Cambeiro M; Arbea L; Jablonska P; Moreno-Jiménez M; Amillo S; Aristu J; Lecanda F; Martinez-Monge R
Radiother Oncol; 2019 Jun; 135():91-99. PubMed ID: 31015176
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
26. Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma.
Haitz K; Khosravi H; Lin JY; Menge T; Nambudiri VE
J Am Acad Dermatol; 2020 Jul; 83(1):189-196. PubMed ID: 32004650
[TBL] [Abstract][Full Text] [Related]
27. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract][Full Text] [Related]
28. Talimogene laherparepvec: First in class oncolytic virotherapy.
Conry RM; Westbrook B; McKee S; Norwood TG
Hum Vaccin Immunother; 2018 Apr; 14(4):839-846. PubMed ID: 29420123
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.
MacDermed DM; Miller LL; Peabody TD; Simon MA; Luu HH; Haydon RC; Montag AG; Undevia SD; Connell PP
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1147-53. PubMed ID: 19577863
[TBL] [Abstract][Full Text] [Related]
30. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
31. Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.
Gutzmer R; Harrington KJ; Hoeller C; Lebbé C; Malvehy J; Öhrling K; Downey G; Dummer R
Eur J Dermatol; 2018 Dec; 28(6):736-749. PubMed ID: 30698145
[TBL] [Abstract][Full Text] [Related]
32. A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
Mundt AJ; Vijayakumar S; Nemunaitis J; Sandler A; Schwartz H; Hanna N; Peabody T; Senzer N; Chu K; Rasmussen CS; Kessler PD; Rasmussen HS; Warso M; Kufe DW; Gupta TD; Weichselbaum RR
Clin Cancer Res; 2004 Sep; 10(17):5747-53. PubMed ID: 15355902
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of talimogene laherparepvec for the treatment of melanoma.
Broman KK; Zager JS
Expert Opin Biol Ther; 2020 Jan; 20(1):9-14. PubMed ID: 31690129
[No Abstract] [Full Text] [Related]
34. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
[TBL] [Abstract][Full Text] [Related]
35. Intraoperative radiotherapy for extremity soft-tissue sarcomas: can long-term local control be achieved?
Carbó-Laso E; Sanz-Ruiz P; Calvo-Haro JA; Cuervo-Dehesa M; Pérez-Mañanes R; Mediavilla-Santos L; Sánchez-Pérez C; Álvarez-González A; Vaquero-Martín J
Int J Clin Oncol; 2017 Dec; 22(6):1094-1102. PubMed ID: 28717856
[TBL] [Abstract][Full Text] [Related]
36. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
37. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
Chitnis SD; Seim NB; Kendra K
J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
[TBL] [Abstract][Full Text] [Related]
38. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
Tseng WW; Zhou S; To CA; Thall PF; Lazar AJ; Pollock RE; Lin PP; Cormier JN; Lewis VO; Feig BW; Hunt KK; Ballo MT; Patel S; Pisters PW
Cancer; 2015 Oct; 121(20):3659-67. PubMed ID: 26177983
[TBL] [Abstract][Full Text] [Related]
39. Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced Melanoma.
Tam A; Ladbury C; Kassardjian A; Modi B; McGee H; Melstrom L; Margolin K; Xing Y; Amini A
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893072
[TBL] [Abstract][Full Text] [Related]
40. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
